CVS Caremark Corp. expects to lose about 10% of patients enrolled in one of its Medicare prescription drug plans because of a government marketing ban but does not expect the decrease to have a significant impact on its long-term results.
CVS Medicare issues taking longer than planned, profit up
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.